The Use of D-Optimal Mixture Design in Optimizing Development of Okara Tablet Formulation as a Dietary Supplement

Table 3

Actual and predicted values for hardness and friability of okara tablet formulation.

Ingredients	Actual hardness (kN)	Predicted hardness (kN)	Hardness RSE; (%)	Actual friability (%)	Predicted friability (%)	Friability; RSE; (%)
F1	116.84	116.96	0.1017	1.342	1.147	16.9891
F2	83.78	84.01	0.2697	1.731	1.730	0.0602
F3	68.37	70.75	3.3625	1.896	1.957	3.1653
F4	124.25	120.81	2.8433	0.940	0.968	2.7952
F5	73.88	78.13	5.4446	1.229	2.012	38.8902
F6	48.45	50.49	4.0368	2.382	2.53023	5.8732
F7	83.73	100.46	16.6572	1.236	1.366	9.5770
F8	39.16	34.03	15.0890	3.268	2.865	14.0424
F9	60.25	61.64	2.2494	2.600	2.447	6.2418
F10	71.84	73.85	2.7251	1.670	2.073	19.4233
F11	46.28	75.28	38.5186	2.179	1.953	11.5650
F12	84.65	97.32	13.0164	1.310	1.511	13.2689
F13	31.74	57.04	44.3645	2.044	2.373	13.8413
F14	97.88	94.50	3.5751	1.671	1.635	2.1961
F15	81.81	85.76	4.6016	1.755	1.713	2.4478
F16	83.78	84.01	0.2697	1.878	1.730	8.5422
F17	72.52	70.75	2.5033	1.881	1.957	3.9171
F18	64.24	61.64	4.2255	2.295	2.447	6.2346
F19	116.84	116.96	0.1017	1.229	1.147	7.0760
F20	121.21	120.81	0.3319	1.064	0.968	10.0074